# Enhancing sepsis management: the role of dynamic heparin-binding protein monitoring in elderly patients

**Authors:** Lei Miao, Dandan Liu, Jingxian Liao, Xiaozhu Shen, Chunhui Xie, Guangyun Hu

PMC · DOI: 10.3389/fmed.2025.1538515 · Frontiers in Medicine · 2025-06-11

## TL;DR

This study shows that tracking heparin-binding protein (HBP) levels over time can help predict outcomes in elderly sepsis patients, improving risk assessment and treatment decisions.

## Contribution

The study introduces dynamic HBP monitoring as a novel method for risk stratification in elderly septic patients.

## Key findings

- HBP levels were significantly higher in non-survivors compared to survivors at all time points.
- The combined model of HBP and CRP showed improved predictive accuracy over time, with AUC values up to 0.803 on day 20.
- Dynamic HBP levels effectively predicted 28-day mortality risk across all subgroups.

## Abstract

Sepsis is a life-threatening condition with particularly high mortality rates among the elderly. This study investigates the dynamic monitoring of heparin-binding protein (HBP) levels as prognostic biomarkers to improve risk stratification and management in elderly septic patients.

We conducted a retrospective cohort study involving patients aged 65 and older who were hospitalized for sepsis. Data were extracted from electronic medical records, including demographic, clinical, and laboratory information. We analyzed the relationship between dynamic HBP levels and 28-day mortality using linear mixed-effects models to assess the effects of time and prognostic groups.

Among 386 elderly septic patients, the 28-day mortality rate was 20.73%. HBP levels were significantly elevated at all time points in the mortality group compared to the survival group (p < 0.001). The linear mixed-effects model indicated that time, prognosis group, and their interaction significantly influenced HBP levels. In the survival group, HBP levels decreased significantly over time, whereas the mortality group exhibited a smaller reduction, with HBP levels remaining elevated overall. The prognostic predictive ability of HBP improved at various time points, with the combined model of HBP and C-reactive protein (CRP) showing time-varying area under the curve (AUC) values: 0.728 on day 10, 0.744 on day 15, and 0.803 on day 20. The time-dependent ROC curve demonstrated that the combined model consistently exhibited superior discriminative ability throughout the follow-up period. Additionally, the time-dependent Cox regression model indicated that dynamic HBP levels effectively predicted 28-day mortality risk across all subgroups (p < 0.001).

Dynamic monitoring of HBP levels may aid in risk stratification and support clinical decision-making. Further prospective studies are required to evaluate its clinical utility and potential impact on patient management.

## Full-text entities

- **Genes:** AZU1 (azurocidin 1) [NCBI Gene 566] {aka AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** septic (MESH:D001170), Sepsis (MESH:D018805)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12187651/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12187651/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC12187651/full.md

---
Source: https://tomesphere.com/paper/PMC12187651